We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$677M
AUM Growth
+$37.3M
Cap. Flow
-$50.9M
Cap. Flow %
-7.52%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$41.1M
2
AXGN icon
Axogen
AXGN
+$9.76M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXG icon
1
MiMedx Group
MDXG
$630M
$292M 43.2%
23,376,623
– –
BVS icon
2
Bioventus
BVS
$1.16B
$213M 31.45%
12,096,702
– –
VERO
3
DELISTED
Venus Concept
VERO
$38.6M 5.7%
75,260
– –
EYPT icon
4
EyePoint Inc
EYPT
$1.13B
$37.7M 5.57%
4,190,921
– –
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
$37.3M 5.51%
1,333,692
-1,426,258
-52% -$41.1M
AXGN icon
6
Axogen
AXGN
$2.61B
$27.6M 4.08%
1,276,645
-483,054
-27% -$9.76M
TELA icon
7
TELA Bio
TELA
$35.4M
$25.5M 3.76%
1,580,089
– –
MNOV icon
8
MediciNova
MNOV
$65M
$4.7M 0.69%
1,105,941
– –
GYRE icon
9
Gyre Therapeutics
GYRE
$704M
$340K 0.05%
10,483
– –

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
ACM
Avos Capital Management Seattle, Washington $253M AUM 13.56% 1-Year Est. Return

Essex Woodlands Management's Q2 2021 Portfolio in Review

As of Q2 2021, Essex Woodlands Management held 9 positions worth $677M, up 5.8% from $640M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management withdrew a net $50.9M in Q2 2021, reducing 2 holdings. Its largest reduction was Revance Therapeutics, Inc., cutting an estimated $41.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Essex Woodlands Management's biggest Q2 2021 reduction was Revance Therapeutics, Inc., cutting an estimated $41.1M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $677M portfolio in Q2 2021.
  • Essex Woodlands Management opened 0 new positions and closed 0 in Q2 2021.
  • Essex Woodlands Management's portfolio value rose 5.8% quarter-over-quarter to $677M.

Based on Essex Woodlands Management's 13F filing for Q2 2021, filed 13 Aug 2021.